Xiao Teng, Desiree Abdurrachim, Ashmita Saigal, Qiang Yang, Gideon Ho, Malte Hasle Nielsen, Susanne E. Pors, Chih-Liang Chin, Saswata Talukdar, Asad Abu Bakar Ali, and Michael Feigh
European Association for the Study of the Liver (EASL) Annual Congress 2020
HistoIndex and ILBS Launch Centre of Excellence in New Delhi for Advanced Diagnostics and Clinical Research on Nonalcoholic Steatohepatitis (NASH) [Picture by Enterprise Singapore. From Left] Professor Balram Bhargava, Director General, Indian Council of Medical Research; Secretary, Department of Health Research, India, Mr Lim Thuan Kuan, High Commissioner of the Republic of Singapore in …
Wang, Bingqiong, et al. Modern Pathology 31.10 (2018): 1567-1577.
Wang, Y., et al. Journal of Viral Hepatitis 25.5 (2018): 598-607.
Histolndex Contributed to the Development of the First FDA-Approved MASH Treatment The Road to Rezdiffra After many years of development, Madrigal received accelerated approval from the FDA for Rezdiffra™ (resmetirom), making it the first and only medication approved for the treatment of NASH (also known as “MASH”) in patients with noncirrhotic NASH with moderate to …
Digital Pathology: The Future of Diagnosis Driven by AI Digital pathology refers to the digitalization of glass slides for computational analysis. It involves scanning tissue sections at high resolution to create whole slide images (WSI) that can be stored, managed, viewed, analyzed and shared digitally. Artificial intelligence provides cutting-edge analytics to maximize the findings from …
Impact of sampling size on variability of fibrosis assessment in liver biopsies using SHG TPE and AI analysis based fibrosis staging November 12, 2023 NITs as continuous measure of hepatic fibrosis in NAFLD November 11, 2023 Validation of the HI AI DP platform as an aiding tool to increase pathologist concordance on fibrosis staging in …
HistoIndex Presents Advancements in AI-powered Stain-free Tissue Imaging for NASH Clinical Trials at EASL Congress 2023 June 21, 2023 TANDEM study shows potential of HistoIndex SHG/TPE imaging and AI-based technology in evaluating the effects of combination therapy for NASH June 15, 2023 HistoIndex SHG/TPE imaging and AI-based technology reveals dose-dependent effectiveness of Tropifexor for NASH …
What we do Developing new standards in complementary diagnostics We specialize in stain-free AI digital pathology for drug development and clinical diagnosis. Using a stain-free biophotonic imaging technique called Second Harmonic Generation (SHG) and an AI image-analysis, we detect and quantify morphological features like fibrosis within tissues in a consistent and reproducible manner. Our Founders …
Singapore HQ
Teletech Park
20 Science Park Road, #01-26/27
Singapore 117674
UK Branch
Queen Elizabeth University Hospital,
Imaging Centre of Excellence, L3-18, Langlands Drive, Glasgow G51 4LB,
United Kingdom
China Subsidiary Office
Room 1001, Building 10
No. 188 Binkang Road, Hangzhou
Zhejiang 310051, China
©2024 Histoindex Pte Ltd. All Rights Reserved. All logos and trademarks are the property of HistoIndex or their respective owners.